Abstract
Cholesterol has gained tremendous attention as an essential lipid in the life cycle of virtually all viruses. These seem to have developed manifold strategies to modulate the cholesterol metabolism to the side of lipid uptake and de novo synthesis. In turn, affecting the cholesterol homeostasis has emerged as novel broad-spectrum antiviral strategy. On the other hand, the innate immune system is similarly regulated by the lipid and stimulated by its derivatives. This certainly requires attention in the design of antiviral strategies aiming to decrease cellular cholesterol, as evidence accumulates that withdrawal of cholesterol hampers innate immunity. Secondly, there are exceptions to the rule of the abovementioned virus-induced metabolic shift toward cholesterol anabolism. It therefore is of interest to dissect underlying regulatory mechanisms, which we aimed for in this minireview. We further collected evidence for intracellular cholesterol concentrations being less important in viral life cycles as compared to the spatial distribution of the lipid. Various routes of cholesterol trafficking were found to be hijacked in viral infections with respect to organelle-endosome contact sites mediating cholesterol shuttling. Thus, re-distribution of cellular cholesterol in the context of viral infections requires more attention in ongoing research. As a final aim, a pan-antiviral treatment could be found just within the transport and re-adjustment of local cholesterol concentrations. Thus, we aimed to emphasize the importance of the regulatory roles the endosomal system fulfils herein and hope to stimulate research in this field.
Introduction
Viral infections certainly present one of the biggest concerns of our society leading to a tremendous number of deaths worldwide. In the fight against virus-induced diseases, several antiviral medications have emerged and were approved (de Clercq and Li, 2016). However, the majority of these compounds are either specific for a class of viruses, induce heavy adverse effects, or lead to viral escape mutations (Sleijfer et al., 2005; de Clercq and Li, 2016; Domingo et al., 2019). Thus, a search for a tolerable and pan-antiviral therapy has emerged. A strong focus now is set on affecting the host’s cholesterol metabolic network (Lembo et al., 2016; Yuan et al., 2019; Gorabi et al., 2020). For reasons explained in this article, a variety of studies focus on the reduction of cellular cholesterol. Recent evidence implies that this may not only present a strategy against enveloped viruses. Various non-enveloped viruses make use of the exosomal pathway or autophagy for their release, thus being dependent on membranous processes just as well (Jiang et al., 2011; Zhang et al., 2021). Consequently, the majority of studies follow the assumption that a certain net amount of cellular cholesterol per se is required in viral life cycles. While this may be true for various viruses, some examples demonstrated that cholesterol depletion actually behaves provirally (Jung et al., 2012; Blanchet et al., 2016; Glitscher et al., 2021). While altering the cholesterol homeostasis in the host appears as a promising pan-antiviral strategy, ambiguous behaviors hinder the progress in finding exactly this. A problem therefore addressed by us is that it may not come down to how much cholesterol resides within a cell. Rather, we believe, it is important where and how the cholesterol pool is distributed within a cell. We therefore try to give an overview of the current knowledge, gaps in knowledge, and possible prospects in how cholesterol trafficking mediated by endosomes may be useful to this overall aim.
Modulation of Cellular Cholesterol Content in Viral Infections
Cholesterol Synthesis and Uptake
A wide range of viruses induces cholesterol anabolism, suggesting a general shift toward cholesterol uptake and de novo synthesis in infected cells. Central processes hereof are transcriptionally regulated by sterol-regulatory element binding proteins (SREBPs). These ER-resident proteins are maintained in a complex together with insulin-induced gene 1 (INSIG1), SREBP cleaving-activating protein (SCAP), and sterols (Yang et al., 2002). Upon depletion of the latter, INSIG1 dissociates and the SREBP-SCAP complex traffics to the Golgi apparatus (Sun et al., 2007). Subsequent cleavage releases the transcription factor (TF) domain to be shuttled into the nucleus (Wang et al., 1994). Herein, SREBPs drive the expression of a variety of genes being responsible for increasing cellular cholesterol. Two major key players are the 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMGCR), catalyzing the rate-limiting step in cholesterol synthesis (Geelen et al., 1986), and the low-density lipoprotein (LDL) receptor (Yokoyama et al., 1993), binding the major cholesterol-carrying lipoprotein. This point of control is hijacked by a variety of viruses. Human cytomegalovirus (HCMV), hepatitis B virus (HBV) or hepatitis C virus (HCV) activate SREBP activity through enhancing its proteolytic cleavage (Waris et al., 2007; Yu et al., 2012; Qiao et al., 2013). Additionally, a correlation between early viral infections and a rise in LDL uptake and cholesterol biosynthesis were observed for Dengue virus (DENV) or West Nile virus (WNV; Mackenzie et al., 2007; Soto-Acosta et al., 2013). Also for non-enveloped viruses, such as the Coxsackievirus B3 (CVB3), an activation of SREBPs was observed (Wang et al., 2018) and may be similarly important for viruses making use of the exosomal pathway, such as Enterovirus 71 (EV71), human Norovirus (HuNoV), Rotaviruses, or encephalomyocarditis virus (EMCV; Owusu et al., 2021). Following these findings, cholesterol removal from infected cells could correlate with benefits for a viral infection.
Cholesterol Export
On the other hand, cholesterol depleting processes need to be taken into account, which are majorly regulated via two different nuclear receptors acting as TFs: (i) liver X receptors (LXR) and (ii) farnesoid X receptors (FXR). The former is activated by sterols and oxysterols (Janowski et al., 1996) and primes expression of the cholesterol export program. Among various targets, ATP-binding cassette transporter A1 (ABCA1) is induced, which shuttles cholesterol into the extracellular space. This process is aided by cholesterol transport from endolysosomes to the plasma membrane (PM) via, for example, the Niemann-Pick C1 protein (NPC1; Boadu and Francis, 2006; Boadu et al., 2012). As a result, high-density lipoprotein (HDL) is formed with the help of ATP-binding cassette transporter G1 (ABCG1) and apolipoprotein A1 (ApoA1) leading to cholesterol export from cells (Gelissen et al., 2006; Zhao et al., 2012). At this level, viruses, such as human immunodeficiency virus (HIV), HCV, and HCMV, have been demonstrated to impair ABCA1 activity via reduced expression (Mujawar et al., 2006; Sanchez and Dong, 2010; Shirasaki et al., 2013). Further, both HBV and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seem to decrease ApoA1 levels (Wang et al., 2016; Yang et al., 2020), thereby also reducing HDL-related cholesterol export. Effectively, these regulations would match to an increase in cholesterol anabolism, thus increasing the lipid in an infected cell.
Cholesterol Derivatization
Apart from cholesterol export, derivatization into bile acids (BAs) is a way to rid a cell from the lipid specifically in liver tissue. The expression of both rate-limiting enzymes, namely, the ER-resident cholesterol 7 alpha-hydroxylase (CYP7A1) or the mitochondrial sterol 27-hydroxylase (CYP27A1), is induced by LXR (Gupta et al., 2002; Szanto et al., 2004). Once primary bile acids are synthesized, FXR represses these anabolic enzymes (Forman et al., 1995; Chiang, 2015) and enhances BA export via ATP-binding cassette transporter B11 (ABCB11; Ananthanarayanan et al., 2001; Deng et al., 2006) or the organic solute transporter subunit alpha and beta (OSTα/β; Ballatori et al., 2005; Landrier et al., 2006). Both LXR and FXR activity is fine-tuned by co-factors represented by the nuclear receptors retinoic X receptors (RXR) or peroxisome proliferator-activated receptors (PPARs; Seol et al., 1995; Kassam et al., 2003; Pineda Torra et al., 2003). As a liver-specific process, BA synthesis and export are mainly affected by enteric and hepatotropic viruses. For instance, an activation of FXR is related to proviral effects for HBV, HCV, or HuNoV (Scholtes et al., 2008; Mouzannar et al., 2019; Murakami et al., 2020). In turn, the activation of FXR would result in an impaired BA synthesis and render cholesterol levels to rise. This again supports the claim of viruses elevating cellular cholesterol.
Cholesterol Storage
A third way of removing cholesterol from a cell is via esterification and subsequent intracellular storage. This catalytic process is mediated by the ER-resident acyl-coenzyme A:cholesterol acyltransferase (ACAT), which is activated by cholesterol (Cheng et al., 1995). As a consequence, cholesterol esters are stored in lipid droplets (LDs) rendering cholesterol to be biologically inactive. The morphogenesis and depletion of LDs are strictly coordinated (Olzmann and Carvalho, 2019) and similarly are made use of by different viruses. The predominant example is HCV, which strongly depends on these structures for virion morphogenesis (Barba et al., 1997; Boulant et al., 2007). However, also a variety of other viruses induce the formation of LDs among which are DENV, Zika virus (ZIKV), Herpes simplex virus 1 (HSV-1), Influenza A virus (IAV; Samsa et al., 2009; Monson et al., 2021), and Adenovirus RIDα (Cianciola et al., 2013). Consequently, viruses requiring LDs present a group contradicting with a general increase in biologically available net cholesterol content in cells. While they do require cholesterol synthesis and uptake, it would then be stored rather than being available within membranes.
Innate Immunity
Pathogen Recognition Receptors
Just as viral life cycles, the innate immune response against the pathogens is regulated by cholesterol, which is initiated by pathogen-associated molecular patterns (PAMPs) being sensed by pathogen recognition receptors (PRRs). Here, toll-like receptors (TLRs) represent PRRs being either present on the PM or within endosomes majorly recognizing nucleic acids (Latz et al., 2004; Nishiya et al., 2005; Husebye et al., 2006; Johnsen et al., 2006; Nilsen et al., 2008; Ishii et al., 2014; Lester and Li, 2014). They share a close relationship with ABCA1-dependent cholesterol removal, which interferes with downstream cascades and vice versa (Zhu et al., 2008, 2010; Guo et al., 2015; Li et al., 2018; Ding et al., 2020). Similarly, TLR activity seems to decline upon application of statins, inhibitors of cholesterol synthesis (Mullen et al., 2015; Bahrami et al., 2018; Venardos et al., 2018). A second class of PRRs is represented by retinoic acid-inducible gene-I-like receptors (RIG-I-like receptors or RLRs). An activation by PAMPs subsequently triggers oligomerization of mitochondrial antiviral signaling protein (MAVS) on the outer mitochondrial membrane, which passes signaling on to the production of IFNs (Zamorano Cuervo et al., 2018; Rehwinkel and Gack, 2020). While little is known about cholesterol controlling the related pathway, RIG-I signaling seems to involve the oxysterol 25-hydroxycholesterol (Wang et al., 2012). Further, the predominant localization of MAVS at ER-mitochondrion contact sites with high cholesterol content (Horner et al., 2011) implies that its oligomerization could be regulated by local cholesterol concentrations. Further elucidation is required to understand these relationships in detail.
Interferon Response
Downstream of PRRs, respective signaling cascades elicit the production of cytokines among which are IFNs. These result in myriads of regulatory alterations in targeted cells, ultimately mediating host-defense mechanisms. An interesting link to cholesterol can be drawn by IFNs inducing a key enzyme in the buildup of cholesterol-derivatives, namely, cholesterol 25-hydroxylase (CH25H). The latter produces an oxysterol, 25-hydroxycholesterol, which has been described as broadly antiviral via diverse mechanisms (Zhao et al., 2020) against, for example, HSV, IAV, SARS-CoV-2, and members of the Flaviviridae or Filoviridae families (Liu et al., 2013; Chen et al., 2014; Wang et al., 2020). In general, oxysterols also serve important functions in regulating the IFN response and production of the cytokines. Oxysterol production is inducible by IFNs (Marquis et al., 2011; Blanc et al., 2013).These in turn activate LXR (Lehmann et al., 1997), which boosts production of IFNγ (Wang Q. et al., 2014). This could serve the purpose of inducing antiviral activity, as LXR has been described to induce viral restriction if induced pharmacologically (Sheng et al., 2016; Lange et al., 2018, 2019; Mlera et al., 2021). Further, oxysterols themselves exert similar antiviral effects against manifold viruses (Civra et al., 2014, 2018; Anggakusuma et al., 2015; Willard et al., 2018; Marcello et al., 2020; Zu et al., 2020; Glitscher et al., 2021). Opposing to this, however, stand studies describing a negative feedback loop of IFNγ reducing LXR and FXR activity (Renga et al., 2009; Pascual-García et al., 2013). Effectively, this would increase cellular cholesterol levels, as observed in further studies (Hao et al., 2013; Robertson and Ghazal, 2016; Kühnl et al., 2018). More research is required elucidating the mechanism regulating these opposing effects especially with respect to the change in net cholesterol, which previously was assumed to be essential to viruses.
Inflammasome
The inflammasome is a multiprotein complex and a prime mediator for inflammatory processes and pyroptosis. Upon establishment of cellular stress or exposure to pathogens and subsequent PAMP-sensing, different subunit combinations of the complex assemble. In its core, homo-oligomers of either pro-caspase 1 or 8 are found. These may then be followed by an accessory proteins connecting the inner core with the outer subunits mediating specificity toward the activating agent. These outer subunits are represented by NLR family CARD domain-containing protein 4 (NLRC4), NLR family pyrin domain-containing 3, 6, or 7 (NLRP3/6/7), interferon-inducible protein AIM2 (AIM2), gamma-interferon-inducible protein Ifi-16 (IFI16), or pro-caspases 11, 4, or 5. As a result upon activation, the inner caspases proteolytically activate interleukins 1β and 18 (IL1β/18), mediating inflammation, or gasdermin D, initiating pyroptosis (Zheng et al., 2020). Interestingly, the inflammasome presents an additional step regulated by cholesterol. Efficient activation of the complex machinery by NLRP3 hereby is reliant on cholesterol shuttling to the ER (de La Roche et al., 2018) and enhanced by cholesterol accumulation (Le Bras, 2018). In line with this, cholesterol efflux reduces the activity of the inflammasome (Westerterp et al., 2018). Concordantly, the activation of SREBP-mediated cholesterol synthesis seems to be enhanced by the latter (Im et al., 2011; Li et al., 2013; Guo et al., 2018) and sets LD-mediated, virus-induced inflammatory responses into a fitting context (Negash et al., 2013; Dias et al., 2020).
Cholesterol in the Endosomal System
As implied by mechanisms summarized above and in Figure 1, cholesterol affects a variety of steps in the cellular and thereby viral life cycle. Although almost all viruses have an impact on cholesterol metabolism and cholesterol import, there are profound differences with respect to the effect of cholesterol on the viral life cycle. In light of this, it appears rational to affect a central factor involved in cholesterol uptake and intracellular transport as a target for antiviral therapies. One such factor is represented by the endosomal system, which primarily is described as the transporting machinery from components of the extracellular space to intracellular organelles. Primed by endocytosis, early endosomes (EEs) are formed close to the PM. These can either differentiate into recycling endosomes (REs) flowing into the endosomal recycling compartment (ERC), from where cargo is shuttled back to the PM (Xie et al., 2016), or they can mature into late endosomes (LEs; Stoorvogel et al., 1991). On the way from EEs to LEs, the endosomal system can be fed via two further routes: (i) vesicles originating from the trans-Golgi network (TGN; Burd and Cullen, 2014; Nagano et al., 2019), aiding in endosomal maturation, and (ii) autophagosomes (Gordon and Seglen, 1988; Ganesan and Cai, 2021), mediating cargo release (Claude-Taupin et al., 2017) or degradation. Further, cargo loading of the endosomal system is mediated by a distinct subset of late endosomes, namely, multivesicular bodies (MVBs). Sorting herein is mediated by the endosomal complexes required for transport (ESCRT) machinery (Frankel and Audhya, 2018), which incorporates molecules into intraluminal vesicles, hence the name MVBs. Cargo, being either protein, nucleic acids or lipids, is then targeted for release via exosomes (Hessvik and Llorente, 2018) or degradation via fusion with lysosomes (LYs; Mullock et al., 1998).
Figure 1
Endosomal Flux Is Regulated by Cholesterol Content
Cholesterol fulfils central regulatory roles within the endosomal system. The lipid affects membrane curvature (Chen and Rand, 1997; Lee et al., 2020), thickness (de Meyer and Smit, 2009), fluidity (Cooper, 1978), and lipid microdomains (Sobo et al., 2007). It thereby regulates recruitment of integral and peripheral membrane proteins to lipid rafts and raft-like clusters (Melkonian et al., 1999; Levental et al., 2010; Lorent et al., 2017). This in turn is essential to endosomal flux, as there are continuous vesicular fission and fusion events. The latter are mainly regulated via soluble NSF attachment protein receptors (SNAREs). Both clustering and activity hereof is enhanced by cholesterol (Lang et al., 2001; Milovanovic et al., 2015; Stratton et al., 2016), which renders the lipid being intertwined with the fate of vesicular fusion. On the other hand, endosomal cholesterol also regulates and is regulated by dynamin-mediated vesicle fission (Robinet et al., 2006; Anderson et al., 2021) and is required for ESCRT-mediated ILV scission (Kobayashi et al., 2002; Boura et al., 2012; Bissig and Gruenberg, 2013). This strict regulation of membrane fusion and fission by cholesterol is accompanied by directed trafficking of endosomes along microtubules in the process of their maturation. Here, high endosomal cholesterol concentrations leads to recruitment of the dynein/dynactin motor complex and thereby mediates retrograde vesicle transport (Jordens et al., 2001; Thakur et al., 2020). This finally serves the purpose guaranteeing a functional cholesterol trafficking to its destination.
Cholesterol Distribution Is Mediated via the Endosomal System
The endolysosomal systems marks the final destination for endocytosed cholesterol. From here on, the lipid will be re-distributed toward other organelles or toward the place of storage, which requires an intricate combination of shuttling proteins and organelle-organelle adaptor proteins. Once inside LEs or LYs, cholesterol is mobilized with the help of carrier proteins, such as lysosome-associated membrane glycoprotein 2 (LAMP2; Li and Pfeffer, 2016), saposins (Saps; Locatelli-Hoops et al., 2006), lysosomal integral membrane protein-2 (LIMP-2; Heybrock et al., 2019), or the NPC1/2 system (Watari et al., 1999; Infante et al., 2008). Subsequently, cholesterol is distributed to different organelles through organelle-organelle contact sites. Among these are synaptotagmin 7 (Syt7) mediating contacts to peroxisomes (Chu et al., 2015), mitofusin 2 (Mfn2), and vacuolar protein sorting-associated protein 13A (Vps13A) for mitochondria (Daniele et al., 2014; Muñoz-Braceras et al., 2019), NPC1, oxysterol binding protein-like 1A (ORP1L), Rab-interacting lysosomal protein (RILP), StAR-related lipid transfer domain-containing 3 (STARD3) for the endoplasmic reticulum (ER; Rocha et al., 2009; Wilhelm et al., 2017; Höglinger et al., 2019), or STARD4 for the PM (Iaea et al., 2017). This regulation then is essentially guaranteeing delivery of cholesterol to the ER, where it regulates SREBPs and is stored in LDs, to the site of BA synthesis and to ABCA1 exporting cholesterol, as reviewed elsewhere (Luo et al., 2017; Meng et al., 2020).
Endosomal Cholesterol Trafficking as Shared Feature in Viral Infections
Viral Attachment and Entry
Primed by the characterization of the envelope of IAV (UHLER and GARD, 1954), it became apparent that cholesterol is a central component in a variety of viral envelopes (Aloia et al., 1993; Funk et al., 2008; Bremer et al., 2009; Merz et al., 2011; Gerl et al., 2012; Carro and Damonte, 2013). On the host side, it aids in endocytosis (Rodal et al., 1999) and therefore is required for viral internalization for a wide range of both enveloped and non-enveloped viruses (Ripa et al., 2021). Apart from endocytosed viruses, the lipid is also required for entry of enveloped viruses directly fusing with the PM, such as HIV (Carter et al., 2009) or Kaposi’s sarcoma-associated herpesvirus (KSHV; Raghu et al., 2007). PM cholesterol therefore serves as first regulator in a viral life cycle, which is either supplied by ER-PM contact sites or ERC-PM contact sites. While various adaptors for ER-PM shuttling have been identified (Naito et al., 2019; Li et al., 2021), ERC-PM contacts present as rather enigmatic although evidently being similarly important (Hölttä-Vuori et al., 2002; Möbius et al., 2003; Garbarino et al., 2012; Iaea et al., 2017). Further elucidation of the latter and how it is modulated by viruses thus presents as important aspect of focus. After cholesterol-dependent steps in endocytosis, shuttling of the lipid within virus-containing endosomes further is important for the uncoating, and therefore for final cellular entry, of enveloped viruses, such as members of the Filoviridae family, IAV, HIV, SARS-CoV-2, and Alphaviruses (Schroeder, 2010; Carette et al., 2011; Côté et al., 2011; Garcia-Dorival et al., 2020; Martyna et al., 2020; Sousa et al., 2020). This process is reported to be mediated via cholesterol-shuttling proteins, such as NPC1. Besides the latter, also lysosome-associated membrane glycoprotein 1 (LAMP1), which also is capable of binding cholesterol, has been described to facilitate the cellular entry of Lassa virus (LASV; Hulseberg et al., 2018). As these entry factors represent cholesterol-binding proteins and facilitate viral entry, an involvement of the lipid in, for example, facilitating endosomal escape is evident. Advances in how endosomal cholesterol transport machineries affect different viruses therefore also enhances knowledge on possible entry inhibitors.
Viral Replication
After entry, cholesterol similarly strictly regulates viral replication in manifold cases. For the buildup of the characteristic membranous web around the ER being crucial for HCV replication (Egger et al., 2002; Moradpour et al., 2003), the virus makes use of LE/LYs contact sites and cholesterol trafficking mediated by STARD3, ORP1L, and NPC1 (Stoeck et al., 2018). This recruitment appears to be a similarly important feature for the closely related Flaviviruses (Wang H. et al., 2014; Merino-Ramos et al., 2016; Neufeldt et al., 2018). Although not being known for web formation, the more distantly related CVB3, EMCV and Aichi virus (AiV) seem to share the importance of cholesterol being shuttled to the ER (Albulescu et al., 2015; Ishikawa-Sasaki et al., 2018).
Viral Morphogenesis and Egress
On the side of viral release, virtually all routes of viral egress, including autophagy-induced cell lysis, strictly depend on membrane fusion or fission events. Efficient cholesterol distribution herein is required for the secretory pathway, the exosomal pathway, or direct budding from the plasma membrane (Wang et al., 2000; Ridsdale et al., 2006; Kobuna et al., 2010; Boura et al., 2012). Here, the main focus of research was set on MVBs and related protein complexes. Blockage of the NPC1/2 system, for example, inhibits MVB-dependent HCV release (Elgner et al., 2016) and the life cycle of both DENV and ZIKV (Poh et al., 2012; Sabino et al., 2019). This similarly could expose weaknesses of other viruses as HBV, hepatitis A virus (HAV), and HEV (Lambert et al., 2007; Hoffmann et al., 2013; Nagashima et al., 2014; González-López et al., 2018) or other enteric viruses (Zhang et al., 2021), as they rely on a comparable release pathway. Apart from MVB-located ESCRT, also the budding process of HIV on PMs needs to be regarded (Sundquist and Kräusslich, 2012). Specifically, the requirement of ESCRT-III renders the need of local cholesterol clustering (Morita et al., 2011; Yandrapalli et al., 2016). Here again, ERC-PM contacts may come into play as discussed above. On the other hand, studies point into the direction that NPC1 and lysosomal recruitment to the cell periphery may be involved in maintaining cholesterol supply to these sites of release (Tang et al., 2009; Cinti et al., 2017). These mechanisms directly link endosomal maturation, which relies on cholesterol, to viral release. Which role lysosomes fulfill in the role of virion production, however, needs to be further studied. Reason for this is growing evidence that some viruses, for example, β-Coronaviruses (Ghosh et al., 2020), make use of these organelles for viral release, therefore bringing cholesterol-regulated endolysosomal maturation into focus.
Peroxisomes and Mitochondria
Lastly, organelles being majorly involved in the cholesterol metabolism per se need to be regarded. Both peroxisomes and mitochondria are essential in anabolism and derivatization of cholesterol (Kovacs et al., 2002). As pointed out earlier, cholesterol has the potential to control innate immunity with respect to IFN responses. Additionally, there is growing awareness that its anabolism and its derivatization into oxysterols or BAs mediate central aspects of inflammation (Spann et al., 2012; Perucha et al., 2019; Willinger, 2019; Cardoso and Perucha, 2021). How and if cholesterol trafficking to these organelles affects these mechanisms remains largely elusive so far. One hint can be found in DENV being reported to cleave Mfns (Yu et al., 2015). This in turn could diminish mitochondrial cholesterol levels and subsequently reduce inflammasome activity (Ichinohe et al., 2013). Elucidation of these processes therefore could present useful with respect to other viruses and their relation to inflammatory responses.
Conclusion and Outlook
As presented above and in Figure 2, viruses indeed seem to rely on a certain level of cholesterol within a cell to ensure an ongoing life cycle and therefore perturb the host metabolome. However, by simply reducing cellular cholesterol in an antiviral approach, one could also potentially dampen the immune system, as evidenced previously (Bahrami et al., 2018; Koike et al., 2021). By having a closer look on cholesterol shuttling within the endosomal system, it becomes apparent that viruses strongly rely on an intact lipid flux. Thus, the key to finding a real pan-antiviral strategy may come down to withdrawing cholesterol from where it is needed for viral maintenance rather than reducing it globally. This very mechanism could be achieved by inducing a deliberate accumulation of cholesterol within the endosomal system. Here, recent studies identified this as restrictive action against IAV in the context of an IFN response (Kühnl et al., 2018) and against HEV as a consequence of heavy cholesterol uptake and Fenofibrate application (Glitscher et al., 2021). Similarly, this could explain the broad antiviral effect of lysosomotropic drugs, such as U18666A (Kuzu et al., 2017). While the tools at hand already present promising treatment options against viral infections, more research is required in assessing adverse effects such as lysosomal storage diseases. Thus, advances in clarifying molecular mechanisms and regulators in endosomal cholesterol shuttling may finally lead to the discovery of a tolerable, pan-antiviral therapy.
Figure 2
Funding
This work was supported with a grant by the LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; project D2).
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Author contributions
EH and MG: conceptualization. MG: writing – original draft preparation and visualization. EH: writing – review and editing, supervision, project administration, and funding acquisition. All authors contributed to the article and approved the submitted version.
Acknowledgments
The authors thank the LOEWE Center DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases; project D2) for financial support. The authors further thank Tobias Zahn for proofreading and discussing aspects of the article.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AlbulescuL.WubboltsR.van KuppeveldF. J. M.StratingJ. R. P. M. (2015). Cholesterol shuttling is important for RNA replication of coxsackievirus B3 and encephalomyocarditis virus. Cell. Microbiol.17, 1144–1156. doi: 10.1111/cmi.12425
2
AloiaR. C.TianH.JensenF. C. (1993). Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U. S. A.90, 5181–5185. doi: 10.1073/pnas.90.11.5181
3
AnanthanarayananM.BalasubramanianN.MakishimaM.MangelsdorfD. J.SuchyF. J. (2001). Human bile salt export pump promoter is transactivated by the farnesoid X receptor/bile acid receptor. J. Biol. Chem.276, 28857–28865. doi: 10.1074/jbc.M011610200
4
AndersonR. H.SochackiK. A.VuppulaH.ScottB. L.BaileyE. M.SchultzM. M.et al. (2021). Sterols lower energetic barriers of membrane bending and fission necessary for efficient clathrin mediated endocytosis. bioRxiv [Preprint]. doi: 10.1101/2021.01.31.428633
5
AnggakusumaRomero-BreyI.BergerC.ColpittsC. C.BoldanovaT.EngelmannM.et al. (2015). Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation. Hepatology62, 702–714. doi: 10.1002/hep.27913
6
BahramiA.ParsamaneshN.AtkinS. L.BanachM.SahebkarA. (2018). Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol. Res.135, 230–238. doi: 10.1016/j.phrs.2018.08.014
7
BallatoriN.ChristianW. V.LeeJ. Y.DawsonP. A.SorokaC. J.BoyerJ. L.et al. (2005). OSTalpha-OSTbeta: a major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia. Hepatology42, 1270–1279. doi: 10.1002/hep.20961
8
BarbaG.HarperF.HaradaT.KoharaM.GoulinetS.MatsuuraY.et al. (1997). Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. U. S. A.94, 1200–1205. doi: 10.1073/pnas.94.4.1200
9
BissigC.GruenbergJ. (2013). Lipid sorting and multivesicular endosome biogenesis. Cold Spring Harb. Perspect. Biol.5:a016816. doi: 10.1101/cshperspect.a016816
10
BlancM.HsiehW. Y.RobertsonK. A.KroppK. A.ForsterT.ShuiG.et al. (2013). The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity38, 106–118. doi: 10.1016/j.immuni.2012.11.004
11
BlanchetM.LeQ.-T.SeidahN. G.LabontéP. (2016). Statins can exert dual, concentration dependent effects on HCV entry in vitro. Antivir. Res.128, 43–48. doi: 10.1016/j.antiviral.2016.02.006
12
BoaduE.FrancisG. A. (2006). The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways. J. Mol. Med.84, 266–275. doi: 10.1007/s00109-005-0001-9
13
BoaduE.NelsonR. C.FrancisG. A. (2012). ABCA1-dependent mobilization of lysosomal cholesterol requires functional Niemann-Pick C2 but not Niemann-Pick C1 protein. Biochim. Biophys. Acta1821, 396–404. doi: 10.1016/j.bbalip.2011.11.013
14
BoulantS.Targett-AdamsP.McLauchlanJ. (2007). Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol.88, 2204–2213. doi: 10.1099/vir.0.82898-0
15
BouraE.IvanovV.CarlsonL.-A.MizuuchiK.HurleyJ. H. (2012). Endosomal sorting complex required for transport (ESCRT) complexes induce phase-separated microdomains in supported lipid bilayers. J. Biol. Chem.287, 28144–28151. doi: 10.1074/jbc.M112.378646
16
BremerC. M.BungC.KottN.HardtM.GlebeD. (2009). Hepatitis B virus infection is dependent on cholesterol in the viral envelope. Cell. Microbiol.11, 249–260. doi: 10.1111/j.1462-5822.2008.01250.x
17
BurdC.CullenP. J. (2014). Retromer: a master conductor of endosome sorting. Cold Spring Harb. Perspect. Biol.6:a016774. doi: 10.1101/cshperspect.a016774
18
CardosoD.PeruchaE. (2021). Cholesterol metabolism: a new molecular switch to control inflammation. Clin. Sci.135, 1389–1408. doi: 10.1042/CS20201394
19
CaretteJ. E.RaabenM.WongA. C.HerbertA. S.ObernostererG.MulherkarN.et al. (2011). Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature477, 340–343. doi: 10.1038/nature10348
20
CarroA. C.DamonteE. B. (2013). Requirement of cholesterol in the viral envelope for dengue virus infection. Virus Res.174, 78–87. doi: 10.1016/j.virusres.2013.03.005
21
CarterG. C.BernstoneL.SanganiD.BeeJ. W.HarderT.JamesW. (2009). HIV entry in macrophages is dependent on intact lipid rafts. Virology386, 192–202. doi: 10.1016/j.virol.2008.12.031
22
ChenZ.RandR. P. (1997). The influence of cholesterol on phospholipid membrane curvature and bending elasticity. Biophys. J.73, 267–276. doi: 10.1016/S0006-3495(97)78067-6
23
ChenY.WangS.YiZ.TianH.AliyariR.LiY.et al. (2014). Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci. Rep.4:7242. doi: 10.1038/srep07242
24
ChengD.ChangC. C.QuX.ChangT. Y. (1995). Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. J. Biol. Chem.270, 685–695. doi: 10.1074/jbc.270.2.685
25
ChiangJ. Y. L. (2015). Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases. Hepatology62, 1315–1317. doi: 10.1002/hep.27964
26
ChuB.-B.LiaoY.-C.QiW.XieC.DuX.WangJ.et al. (2015). Cholesterol transport through lysosome-peroxisome membrane contacts. Cell161, 291–306. doi: 10.1016/j.cell.2015.02.019
27
CianciolaN. L.GreeneD. J.MortonR. E.CarlinC. R. (2013). Adenovirus RIDα uncovers a novel pathway requiring ORP1L for lipid droplet formation independent of NPC1. Mol. Biol. Cell24, 3309–3325. doi: 10.1091/mbc.e12-10-0760
28
CintiA.Le SageV.MilevM. P.Valiente-EcheverríaF.CrossieC.MironM.-J.et al. (2017). HIV-1 enhances mTORC1 activity and repositions lysosomes to the periphery by co-opting Rag GTPases. Sci. Rep.7:5515. doi: 10.1038/s41598-017-05410-0
29
CivraA.CagnoV.DonalisioM.BiasiF.LeonarduzziG.PoliG.et al. (2014). Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep.4:7487. doi: 10.1038/srep07487
30
CivraA.FranceseR.GambaP.TestaG.CagnoV.PoliG.et al. (2018). 25-Hydroxycholesterol and 27-hydroxycholesterol inhibit human rotavirus infection by sequestering viral particles into late endosomes. Redox Biol.19, 318–330. doi: 10.1016/j.redox.2018.09.003
31
Claude-TaupinA.JiaJ.MuddM.DereticV. (2017). Autophagy's secret life: secretion instead of degradation. Essays Biochem.61, 637–647. doi: 10.1042/EBC20170024
32
CooperR. A. (1978). Influence of increased membrane cholesterol on membrane fluidity and cell function in human red blood cells. J. Supramol. Struct.8, 413–430. doi: 10.1002/jss.400080404
33
CôtéM.MisasiJ.RenT.BruchezA.LeeK.FiloneC. M.et al. (2011). Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature477, 344–348. doi: 10.1038/nature10380
34
DanieleT.HurbainI.VagoR.CasariG.RaposoG.TacchettiC.et al. (2014). Mitochondria and melanosomes establish physical contacts modulated by Mfn2 and involved in organelle biogenesis. Curr. Biol.24, 393–403. doi: 10.1016/j.cub.2014.01.007
35
de ClercqE.LiG. (2016). Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev.29, 695–747. doi: 10.1128/CMR.00102-15
36
de La RocheM.HamiltonC.MortensenR.JeyaprakashA. A.GhoshS.AnandP. K. (2018). Trafficking of cholesterol to the ER is required for NLRP3 inflammasome activation. J. Cell Biol.217, 3560–3576. doi: 10.1083/jcb.201709057
37
de MeyerF.SmitB. (2009). Effect of cholesterol on the structure of a phospholipid bilayer. Proc. Natl. Acad. Sci. U. S. A.106, 3654–3658. doi: 10.1073/pnas.0809959106
38
DengR.YangD.YangJ.YanB. (2006). Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. J. Pharmacol. Exp. Ther.317, 317–325. doi: 10.1124/jpet.105.097758
39
DiasS. S. G.SoaresV. C.FerreiraA. C.SacramentoC. Q.Fintelman-RodriguesN.TemerozoJ. R.et al. (2020). Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog.16:e1009127. doi: 10.1371/journal.ppat.1009127
40
DingN.LiuN.YangL.HanX.LinL.LongY. (2020). ABCA1 plays an anti-inflammatory role by affecting TLR4 at the feto-maternal interface. Life Sci.259:118390. doi: 10.1016/j.lfs.2020.118390
41
DomingoE.de ÁvilaA. I.GallegoI.SheldonJ.PeralesC. (2019). Viral fitness: history and relevance for viral pathogenesis and antiviral interventions. Pathog. Dis.77:ftz021. doi: 10.1093/femspd/ftz021
42
EggerD.WölkB.GosertR.BianchiL.BlumH. E.MoradpourD.et al. (2002). Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol.76, 5974–5984. doi: 10.1128/JVI.76.12.5974-5984.2002
43
ElgnerF.RenH.MedvedevR.PloenD.HimmelsbachK.BollerK.et al. (2016). The intracellular cholesterol transport inhibitor U18666A inhibits the exosome-dependent release of mature hepatitis C virus. J. Virol.90, 11181–11196. doi: 10.1128/JVI.01053-16
44
FormanB. M.GoodeE.ChenJ.OroA. E.BradleyD. J.PerlmannT.et al. (1995). Identification of a nuclear receptor that is activated by farnesol metabolites. Cell81, 687–693. doi: 10.1016/0092-8674(95)90530-8
45
FrankelE. B.AudhyaA. (2018). ESCRT-dependent cargo sorting at multivesicular endosomes. Semin. Cell Dev. Biol.74, 4–10. doi: 10.1016/j.semcdb.2017.08.020
46
FunkA.MhamdiM.HohenbergH.HeerenJ.ReimerR.LambertC.et al. (2008). Duck hepatitis B virus requires cholesterol for endosomal escape during virus entry. J. Virol.82, 10532–10542. doi: 10.1128/JVI.00422-08
47
GanesanD.CaiQ. (2021). Understanding amphisomes. Biochem. J.478, 1959–1976. doi: 10.1042/BCJ20200917
48
GarbarinoJ.PanM.ChinH. F.LundF. W.MaxfieldF. R.BreslowJ. L. (2012). STARD4 knockdown in HepG2 cells disrupts cholesterol trafficking associated with the plasma membrane, ER, and ERC. J. Lipid Res.53, 2716–2725. doi: 10.1194/jlr.M032227
49
Garcia-DorivalI.Ángel Cuesta-GeijoM.Barrado-GilL.GalindoI.UrquizaJ.Del PuertoA.et al. (2020). Identification of NPC1 as a novel SARS-CoV-2 intracellular target. bioRxiv [Preprint]. doi: 10.1101/2020.12.19.423584
50
GeelenM.GibsonD.RodwellV. (1986). Hydroxymethylglutaryl-CoA reductase - the rate-limiting enzyme of cholesterol biosynthesis. FEBS Lett.201, 183–186. doi: 10.1016/0014-5793(86)80604-4
51
GelissenI. C.HarrisM.RyeK.-A.QuinnC.BrownA. J.KockxM.et al. (2006). ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler. Thromb. Vasc. Biol.26, 534–540. doi: 10.1161/01.ATV.0000200082.58536.e1
52
GerlM. J.SampaioJ. L.UrbanS.KalvodovaL.VerbavatzJ.-M.BinningtonB.et al. (2012). Quantitative analysis of the lipidomes of the influenza virus envelope and MDCK cell apical membrane. J. Cell Biol.196, 213–221. doi: 10.1083/jcb.201108175
53
GhoshS.Dellibovi-RaghebT. A.KervielA.PakE.QiuQ.FisherM.et al. (2020). β-Coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell183, 1520.e14–1535.e14. doi: 10.1016/j.cell.2020.10.039
54
GlitscherM.MartínD. H.WoytinekK.SchmidtB.TabariD.SchollC.et al. (2021). Targeting cholesterol metabolism as efficient antiviral strategy against the hepatitis E virus. Cell. Mol. Gastroenterol. Hepatol.12, 159–180. doi: 10.1016/j.jcmgh.2021.02.002
55
González-LópezO.Rivera-SerranoE. E.HuF.HensleyL.McKnightK. L.RenJ.et al. (2018). Redundant late domain functions of tandem VP2 YPX3L motifs in nonlytic cellular egress of quasi-enveloped hepatitis A virus. J. Virol.92, e01308–e01318. doi: 10.1128/JVI.01308-18
56
GorabiA. M.KiaieN.BianconiV.JamialahmadiT.Al-RasadiK.JohnstonT. P.et al. (2020). Antiviral effects of statins. Prog. Lipid Res.79:101054. doi: 10.1016/j.plipres.2020.101054
57
GordonP. B.SeglenP. O. (1988). Prelysosomal convergence of autophagic and endocytic pathways. Biochem. Biophys. Res. Commun.151, 40–47. doi: 10.1016/0006-291X(88)90556-6
58
GuoL.ChenC.-H.ZhangL.-L.CaoX.-J.MaQ.-L.DengP.et al. (2015). IRAK1 mediates TLR4-induced ABCA1 downregulation and lipid accumulation in VSMCs. Cell Death Dis.6:e1949. doi: 10.1038/cddis.2015.212
59
GuoC.ChiZ.JiangD.XuT.YuW.WangZ.et al. (2018). Cholesterol homeostatic regulator SCAP-SREBP2 integrates NLRP3 inflammasome activation and cholesterol biosynthetic signaling in macrophages. Immunity49, 842.e7–856.e7. doi: 10.1016/j.immuni.2018.08.021
60
GuptaS.PandakW. M.HylemonP. B. (2002). LXR alpha is the dominant regulator of CYP7A1 transcription. Biochem. Biophys. Res. Commun.293, 338–343. doi: 10.1016/S0006-291X(02)00229-2
61
HaoJ.ZhangY.LvX.XuN.LiuQ.ZhaoS.et al. (2013). IFN-γ induces lipogenesis in mouse mesangial cells via the JAK2/STAT1 pathway. Am. J. Phys. Cell Physiol.304, C760–C767. doi: 10.1152/ajpcell.00352.2012
62
HessvikN. P.LlorenteA. (2018). Current knowledge on exosome biogenesis and release. Cell. Mol. Life Sci.75, 193–208. doi: 10.1007/s00018-017-2595-9
63
HeybrockS.KanervaK.MengY.IngC.LiangA.XiongZ.-J.et al. (2019). Lysosomal integral membrane protein-2 (LIMP-2/SCARB2) is involved in lysosomal cholesterol export. Nat. Commun.10:3521. doi: 10.1038/s41467-019-11425-0
64
HoffmannJ.BoehmC.HimmelsbachK.DonnerhakC.RoettgerH.WeissT. S.et al. (2013). Identification of α-taxilin as an essential factor for the life cycle of hepatitis B virus. J. Hepatol.59, 934–941. doi: 10.1016/j.jhep.2013.06.020
65
HöglingerD.BurgoyneT.Sanchez-HerasE.HartwigP.ColacoA.NewtonJ.et al. (2019). NPC1 regulates ER contacts with endocytic organelles to mediate cholesterol egress. Nat. Commun.10:4276. doi: 10.1038/s41467-019-12152-2
66
Hölttä-VuoriM.TanhuanpääK.MöbiusW.SomerharjuP.IkonenE. (2002). Modulation of cellular cholesterol transport and homeostasis by Rab11. Mol. Biol. Cell13, 3107–3122. doi: 10.1091/mbc.E02-01-0025
67
HornerS. M.LiuH. M.ParkH. S.BrileyJ.GaleM. (2011). Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A.108, 14590–14595. doi: 10.1073/pnas.1110133108
68
HulsebergC. E.FénéantL.SzymańskaK. M.WhiteJ. M. (2018). Lamp1 increases the efficiency of lassa virus infection by promoting fusion in less acidic endosomal compartments. MBio9, e01818–e01817. doi: 10.1128/mBio.01818-17
69
HusebyeH.HalaasØ.StenmarkH.TunheimG.SandangerØ.BogenB.et al. (2006). Endocytic pathways regulate toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J.25, 683–692. doi: 10.1038/sj.emboj.7600991
70
IaeaD. B.MaoS.LundF. W.MaxfieldF. R. (2017). Role of STARD4 in sterol transport between the endocytic recycling compartment and the plasma membrane. Mol. Biol. Cell28, 1111–1122. doi: 10.1091/mbc.e16-07-0499
71
IchinoheT.YamazakiT.KoshibaT.YanagiY. (2013). Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection. Proc. Natl. Acad. Sci. U. S. A.110, 17963–17968. doi: 10.1073/pnas.1312571110
72
ImS.-S.YousefL.BlaschitzC.LiuJ. Z.EdwardsR. A.YoungS. G.et al. (2011). Linking lipid metabolism to the innate immune response in macrophages through sterol regulatory element binding protein-1a. Cell Metab.13, 540–549. doi: 10.1016/j.cmet.2011.04.001
73
InfanteR. E.WangM. L.RadhakrishnanA.KwonH. J.BrownM. S.GoldsteinJ. L. (2008). NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc. Natl. Acad. Sci. U. S. A.105, 15287–15292. doi: 10.1073/pnas.0807328105
74
IshiiN.FunamiK.TatematsuM.SeyaT.MatsumotoM. (2014). Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells. J. Immun.193, 5118–5128. doi: 10.4049/jimmunol.1401375
75
Ishikawa-SasakiK.NagashimaS.TaniguchiK.SasakiJ. (2018). Model of OSBP-mediated cholesterol supply to aichi virus RNA replication sites involving protein-protein interactions among viral proteins, ACBD3, OSBP, VAP-A/B, and SAC1. J. Virol.92, e01952–e01917. doi: 10.1128/JVI.01952-17
76
JanowskiB. A.WillyP. J.DeviT. R.FalckJ. R.MangelsdorfD. J. (1996). An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature383, 728–731. doi: 10.1038/383728a0
77
JiangH.WhiteE. J.Ríos-VicilC. I.XuJ.Gomez-ManzanoC.FueyoJ. (2011). Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J. Virol.85, 4720–4729. doi: 10.1128/JVI.02032-10
78
JohnsenI. B.NguyenT. T.RingdalM.TryggestadA. M.BakkeO.LienE.et al. (2006). Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J.25, 3335–3346. doi: 10.1038/sj.emboj.7601222
79
JordensI.Fernandez-BorjaM.MarsmanM.DusseljeeS.JanssenL.CalafatJ.et al. (2001). The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr. Biol.11, 1680–1685. doi: 10.1016/S0960-9822(01)00531-0
80
JungK.WangQ.KimY.ScheuerK.ZhangZ.ShenQ.et al. (2012). The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals. PLoS One7:e41619. doi: 10.1371/journal.pone.0041619
81
KassamA.MiaoB.YoungP. R.MukherjeeR. (2003). Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding. J. Biol. Chem.278, 10028–10032. doi: 10.1074/jbc.M208312200
82
KobayashiT.BeuchatM.-H.ChevallierJ.MakinoA.MayranN.EscolaJ.-M.et al. (2002). Separation and characterization of late endosomal membrane domains. J. Biol. Chem.277, 32157–32164. doi: 10.1074/jbc.M202838200
83
KobunaH.InoueT.ShibataM.Gengyo-AndoK.YamamotoA.MitaniS.et al. (2010). Multivesicular body formation requires OSBP-related proteins and cholesterol. PLoS Genet.6:e1001055. doi: 10.1371/journal.pgen.1001055
84
KoikeA.TsujinakaK.FujimoriK. (2021). Statins attenuate antiviral IFN-β and ISG expression via inhibition of IRF3 and JAK/STAT signaling in poly(I:C)-treated hyperlipidemic mice and macrophages. FEBS J.288, 4249–4266. doi: 10.1111/febs.15712
85
KovacsW. J.OlivierL. M.KrisansS. K. (2002). Central role of peroxisomes in isoprenoid biosynthesis. Prog. Lipid Res.41, 369–391. doi: 10.1016/S0163-7827(02)00002-4
86
KühnlA.MusiolA.HeitzigN.JohnsonD. E.EhrhardtC.GrewalT.et al. (2018). Late endosomal/lysosomal cholesterol accumulation is a host cell-protective mechanism inhibiting endosomal escape of influenza A virus. MBio9, e01345–e01318. doi: 10.1128/mBio.01345-18
87
KuzuO. F.ToprakM.NooryM. A.RobertsonG. P. (2017). Effect of lysosomotropic molecules on cellular homeostasis. Pharmacol. Res.117, 177–184. doi: 10.1016/j.phrs.2016.12.021
88
LambertC.DöringT.PrangeR. (2007). Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J. Virol.81, 9050–9060. doi: 10.1128/JVI.00479-07
89
LandrierJ.-F.ElorantaJ. J.VavrickaS. R.Kullak-UblickG. A. (2006). The nuclear receptor for bile acids, FXR, transactivates human organic solute transporter-alpha and -beta genes. Am. J. Physiol. Gastrointest. Liver Physiol.290, G476–G485. doi: 10.1152/ajpgi.00430.2005
90
LangT.BrunsD.WenzelD.RiedelD.HolroydP.ThieleC.et al. (2001). SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J.20, 2202–2213. doi: 10.1093/emboj/20.9.2202
91
LangeP. T.JondleC. N.DarrahE. J.JohnsonK. E.TarakanovaV. L. (2019). LXR alpha restricts gammaherpesvirus reactivation from latently infected peritoneal cells. J. Virol.93, e02071–e02018. doi: 10.1128/JVI.02071-18
92
LangeP. T.SchorlC.SahooD.TarakanovaV. L. (2018). Liver X receptors suppress activity of cholesterol and fatty acid synthesis pathways to oppose gammaherpesvirus replication. MBio9, e01115–e01118. doi: 10.1128/mBio.01115-18
93
LatzE.SchoenemeyerA.VisintinA.FitzgeraldK. A.MonksB. G.KnetterC. F.et al. (2004). TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol.5, 190–198. doi: 10.1038/ni1028
94
Le BrasA. (2018). Cholesterol-dependent inflammasome activation accelerates atherosclerosis. Nat. Rev. Cardiol.15, 318–319. doi: 10.1038/s41569-018-0012-1
95
LeeY. K.YuE.-S.AhnD. J.RyuY.-S. (2020). Elasticity-driven membrane budding through cholesterol concentration on supported lipid monolayer–bilayer junction. Adv. Mater. Interfaces7:2000937. doi: 10.1002/admi.202000937
96
LehmannJ. M.KliewerS. A.MooreL. B.Smith-OliverT. A.OliverB. B.SuJ. L.et al. (1997). Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem.272, 3137–3140. doi: 10.1074/jbc.272.6.3137
97
LemboD.CagnoV.CivraA.PoliG. (2016). Oxysterols: an emerging class of broad spectrum antiviral effectors. Mol. Asp. Med.49, 23–30. doi: 10.1016/j.mam.2016.04.003
98
LesterS. N.LiK. (2014). Toll-like receptors in antiviral innate immunity. J. Mol. Biol.426, 1246–1264. doi: 10.1016/j.jmb.2013.11.024
99
LeventalI.LingwoodD.GrzybekM.CoskunU.SimonsK. (2010). Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. U. S. A.107, 22050–22054. doi: 10.1073/pnas.1016184107
100
LiJ.PfefferS. R. (2016). Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export. elife5:e21635. doi: 10.7554/eLife.21635
101
LiC.QianT.HeR.WanC.LiuY.YuH. (2021). Endoplasmic reticulum-plasma membrane contact sites: regulators, mechanisms, and physiological functions. Front. Cell Dev. Biol.9:627700. doi: 10.3389/fcell.2021.627700
102
LiY.ShenS.DingS.WangL. (2018). Toll-like receptor 2 downregulates the cholesterol efflux by activating the nuclear factor-κB pathway in macrophages and may be a potential therapeutic target for the prevention of atherosclerosis. Exp. Ther. Med.15, 198–204. doi: 10.3892/etm.2017.5404
103
LiY.XuS.JiangB.CohenR. A.ZangM. (2013). Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs. PLoS One8:e67532. doi: 10.1371/journal.pone.0067532
104
LiuS.-Y.AliyariR.ChikereK.LiG.MarsdenM. D.SmithJ. K.et al. (2013). Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity38, 92–105. doi: 10.1016/j.immuni.2012.11.005
105
Locatelli-HoopsS.RemmelN.KlingensteinR.BreidenB.RossochaM.SchoenigerM.et al. (2006). Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity. J. Biol. Chem.281, 32451–32460. doi: 10.1074/jbc.M607281200
106
LorentJ. H.Diaz-RohrerB.LinX.SpringK.GorfeA. A.LeventalK. R.et al. (2017). Structural determinants and functional consequences of protein affinity for membrane rafts. Nat. Commun.8:1219. doi: 10.1038/s41467-017-01328-3
107
LuoJ.JiangL.YangH.SongB.-L. (2017). Routes and mechanisms of post-endosomal cholesterol trafficking: a story that never ends. Traffic18, 209–217. doi: 10.1111/tra.12471
108
MackenzieJ. M.KhromykhA. A.PartonR. G. (2007). Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe2, 229–239. doi: 10.1016/j.chom.2007.09.003
109
MarcelloA.CivraA.Milan BonottoR.Nascimento AlvesL.RajasekharanS.GiacoboneC.et al. (2020). The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients. Redox Biol.36:101682. doi: 10.1016/j.redox.2020.101682
110
MarquisJ.-F.KapoustinaO.LanglaisD.RuddyR.DufourC. R.KimB.-H.et al. (2011). Interferon regulatory factor 8 regulates pathways for antigen presentation in myeloid cells and during tuberculosis. PLoS Genet.7:e1002097. doi: 10.1371/journal.pgen.1002097
111
MartynaA.BahsounB.MadsenJ. J.JacksonF. S. J. S.BadhamM. D.VothG. A.et al. (2020). Cholesterol alters the orientation and activity of the influenza virus M2 amphipathic helix in the membrane. J. Phys. Chem. B124, 6738–6747. doi: 10.1021/acs.jpcb.0c03331
112
MelkonianK. A.OstermeyerA. G.ChenJ. Z.RothM. G.BrownD. A. (1999). Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem.274, 3910–3917. doi: 10.1074/jbc.274.6.3910
113
MengY.HeybrockS.NeculaiD.SaftigP. (2020). Cholesterol handling in lysosomes and beyond. Trends Cell Biol.30, 452–466. doi: 10.1016/j.tcb.2020.02.007
114
Merino-RamosT.Vázquez-CalvoÁ.CasasJ.SobrinoF.SaizJ.-C.Martín-AcebesM. A. (2016). Modification of the host cell lipid metabolism induced by hypolipidemic drugs targeting the acetyl coenzyme A carboxylase impairs West Nile virus replication. Antimicrob. Agents Chemother.60, 307–315. doi: 10.1128/AAC.01578-15
115
MerzA.LongG.HietM.-S.BrüggerB.ChlandaP.AndreP.et al. (2011). Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J. Biol. Chem.286, 3018–3032. doi: 10.1074/jbc.M110.175018
116
MilovanovicD.HonigmannA.KoikeS.GöttfertF.PählerG.JuniusM.et al. (2015). Hydrophobic mismatch sorts SNARE proteins into distinct membrane domains. Nat. Commun.6:5984. doi: 10.1038/ncomms6984
117
MleraL.OfferdahlD. K.DorwardD. W.CarmodyA.ChiramelA. I.BestS. M.et al. (2021). The liver X receptor agonist LXR 623 restricts flavivirus replication. Emerg. Microbes Infect.10, 1378–1389. doi: 10.1080/22221751.2021.1947749
118
MöbiusW.van DonselaarE.Ohno-IwashitaY.ShimadaY.HeijnenH. F. G.SlotJ. W.et al. (2003). Recycling compartments and the internal vesicles of multivesicular bodies harbor most of the cholesterol found in the endocytic pathway. Traffic4, 222–231. doi: 10.1034/j.1600-0854.2003.00072.x
119
MonsonE. A.CrosseK. M.DuanM.ChenW.O'SheaR. D.WakimL. M.et al. (2021). Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response. Nat. Commun.12:4303. doi: 10.1038/s41467-021-24632-5
120
MoradpourD.GosertR.EggerD.PeninF.BlumH. E.BienzK. (2003). Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. Antivir. Res.60, 103–109. doi: 10.1016/j.antiviral.2003.08.017
121
MoritaE.SandrinV.McCulloughJ.KatsuyamaA.Baci HamiltonI.SundquistW. I. (2011). ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe9, 235–242. doi: 10.1016/j.chom.2011.02.004
122
MouzannarK.FusilF.LacombeB.OllivierA.MénardC.LotteauV.et al. (2019). Farnesoid X receptor-α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo. FASEB J.33, 2472–2483. doi: 10.1096/fj.201801181R
123
MujawarZ.RoseH.MorrowM. P.PushkarskyT.DubrovskyL.MukhamedovaN.et al. (2006). Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS Biol.4:e365. doi: 10.1371/journal.pbio.0040365
124
MullenL.FerdjaniJ.SacreS. (2015). Simvastatin inhibits toll-like receptor 8 (TLR8) signaling in primary human monocytes and spontaneous tumor necrosis factor production from rheumatoid synovial membrane cultures. Mol. Med.21, 726–734. doi: 10.2119/molmed.2015.00154
125
MullockB. M.BrightN. A.FearonC. W.GrayS. R.LuzioJ. P. (1998). Fusion of lysosomes with late endosomes produces a hybrid organelle of intermediate density and is NSF dependent. J. Cell Biol.140, 591–601. doi: 10.1083/jcb.140.3.591
126
Muñoz-BracerasS.Tornero-ÉcijaA. R.VincentO.EscalanteR. (2019). VPS13A is closely associated with mitochondria and is required for efficient lysosomal degradation. Dis. Model. Mech.12:dmm036681. doi: 10.1242/dmm.036681
127
MurakamiK.TengeV. R.KarandikarU. C.LinS.-C.RamaniS.EttayebiK.et al. (2020). Bile acids and ceramide overcome the entry restriction for GII.3 human norovirus replication in human intestinal enteroids. Proc. Natl. Acad. Sci. U. S. A.117, 1700–1710. doi: 10.1073/pnas.1910138117
128
NaganoM.ToshimaJ. Y.SiekhausD. E.ToshimaJ. (2019). Rab5-mediated endosome formation is regulated at the trans-Golgi network. Commun. Biol.2:419. doi: 10.1038/s42003-019-0670-5
129
NagashimaS.JirintaiS.TakahashiM.KobayashiT.Tanggis NishizawaT.et al. (2014). Hepatitis E virus egress depends on the exosomal pathway, with secretory exosomes derived from multivesicular bodies. J. Gen. Virol.95, 2166–2175. doi: 10.1099/vir.0.066910-0
130
NaitoT.ErcanB.KrshnanL.TrieblA.KohD. H. Z.WeiF.-Y.et al. (2019). Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex. elife8:e51401. doi: 10.7554/eLife.51401
131
NegashA. A.RamosH. J.CrochetN.LauD. T. Y.DoehleB.PapicN.et al. (2013). IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog.9:e1003330. doi: 10.1371/journal.ppat.1003330
132
NeufeldtC. J.CorteseM.AcostaE. G.BartenschlagerR. (2018). Rewiring cellular networks by members of the Flaviviridae family. Nat. Rev. Microbiol.16, 125–142. doi: 10.1038/nrmicro.2017.170
133
NilsenN. J.DeiningerS.NonstadU.SkjeldalF.HusebyeH.RodionovD.et al. (2008). Cellular trafficking of lipoteichoic acid and toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol.84, 280–291. doi: 10.1189/jlb.0907656
134
NishiyaT.KajitaE.MiwaS.DefrancoA. L. (2005). TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem.280, 37107–37117. doi: 10.1074/jbc.M504951200
135
OlzmannJ. A.CarvalhoP. (2019). Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol.20, 137–155. doi: 10.1038/s41580-018-0085-z
136
OwusuI. A.QuayeO.PassalacquaK. D.WobusC. E. (2021). Egress of non-enveloped enteric RNA viruses. J. Gen. Virol.102:001557. doi: 10.1099/jgv.0.001557
137
Pascual-GarcíaM.RuéL.LeónT.JulveJ.CarbóJ. M.MatalongaJ.et al. (2013). Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression. J. Immun.190, 6520–6532. doi: 10.4049/jimmunol.1201393
138
PeruchaE.MelchiottiR.BibbyJ. A.WuW.FrederiksenK. S.RobertsC. A.et al. (2019). The cholesterol biosynthesis pathway regulates IL-10 expression in human Th1 cells. Nat. Commun.10:498. doi: 10.1038/s41467-019-08332-9
139
Pineda TorraI.ClaudelT.DuvalC.KosykhV.FruchartJ.-C.StaelsB. (2003). Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol. Endocrinol.17, 259–272. doi: 10.1210/me.2002-0120
140
PohM. K.ShuiG.XieX.ShiP.-Y.WenkM. R.GuF. (2012). U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antivir. Res.93, 191–198. doi: 10.1016/j.antiviral.2011.11.014
141
QiaoL.WuQ.LuX.ZhouY.Fernández-AlvarezA.YeL.et al. (2013). SREBP-1a activation by HBx and the effect on hepatitis B virus enhancer II/core promoter. Biochem. Biophys. Res. Commun.432, 643–649. doi: 10.1016/j.bbrc.2013.02.030
142
RaghuH.Sharma-WaliaN.VeettilM. V.SadagopanS.CaballeroA.SivakumarR.et al. (2007). Lipid rafts of primary endothelial cells are essential for Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-induced phosphatidylinositol 3-kinase and RhoA-GTPases critical for microtubule dynamics and nuclear delivery of viral DNA but dispensable for binding and entry. J. Virol.81, 7941–7959. doi: 10.1128/JVI.02848-06
143
RehwinkelJ.GackM. U. (2020). RIG-I-like receptors: their regulation and roles in RNA sensing. Nat. Rev. Immunol.20, 537–551. doi: 10.1038/s41577-020-0288-3
144
RengaB.MiglioratiM.MencarelliA.FiorucciS. (2009). Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. Biochim. Biophys. Acta1792, 564–573. doi: 10.1016/j.bbadis.2009.04.004
145
RidsdaleA.DenisM.GougeonP.-Y.NgseeJ. K.PresleyJ. F.ZhaX. (2006). Cholesterol is required for efficient endoplasmic reticulum-to-Golgi transport of secretory membrane proteins. Mol. Biol. Cell17, 1593–1605. doi: 10.1091/mbc.e05-02-0100
146
RipaI.AndreuS.López-GuerreroJ. A.Bello-MoralesR. (2021). Membrane rafts: portals for viral entry. Front. Microbiol.12:631274. doi: 10.3389/fmicb.2021.631274
147
RobertsonK. A.GhazalP. (2016). Interferon control of the sterol metabolic network: bidirectional molecular circuitry-mediating host protection. Front. Immunol.7:634. doi: 10.3389/fimmu.2016.00634
148
RobinetP.FradagradaA.MonierM.-N.MarchettiM.CognyA.MoattiN.et al. (2006). Dynamin is involved in endolysosomal cholesterol delivery to the endoplasmic reticulum: role in cholesterol homeostasis. Traffic7, 811–823. doi: 10.1111/j.1600-0854.2006.00435.x
149
RochaN.KuijlC.van der KantR.JanssenL.HoubenD.JanssenH.et al. (2009). Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 glued and late endosome positioning. J. Cell Biol.185, 1209–1225. doi: 10.1083/jcb.200811005
150
RodalS. K.SkrettingG.GarredO.VilhardtF.van DeursB.SandvigK. (1999). Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol. Biol. Cell10, 961–974. doi: 10.1091/mbc.10.4.961
151
SabinoC.BasicM.BenderD.ElgnerF.HimmelsbachK.HildtE. (2019). Bafilomycin A1 and U18666A efficiently impair ZIKV infection. Viruses11:524. doi: 10.3390/v11060524
152
SamsaM. M.MondotteJ. A.IglesiasN. G.Assunção-MirandaI.Barbosa-LimaG.Da PoianA. T.et al. (2009). Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog.5:e1000632. doi: 10.1371/journal.ppat.1000632
153
SanchezV.DongJ. J. (2010). Alteration of lipid metabolism in cells infected with human cytomegalovirus. Virology404, 71–77. doi: 10.1016/j.virol.2010.04.026
154
ScholtesC.DiazO.IcardV.KaulA.BartenschlagerR.LotteauV.et al. (2008). Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR. J. Hepatol.48, 192–199. doi: 10.1016/j.jhep.2007.09.015
155
SchroederC. (2010). Cholesterol-binding viral proteins in virus entry and morphogenesis. Subcell. Biochem.51, 77–108. doi: 10.1007/978-90-481-8622-8_3
156
SeolW.ChoiH. S.MooreD. D. (1995). Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol.9, 72–85. doi: 10.1210/mend.9.1.7760852
157
ShengX.-X.SunY.-J.ZhanY.QuY.-R.WangH.-X.LuoM.et al. (2016). The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis. Arch. Virol.161, 2491–2501. doi: 10.1007/s00705-016-2950-4
158
ShirasakiT.HondaM.ShimakamiT.HoriiR.YamashitaT.SakaiY.et al. (2013). MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. J. Virol.87, 5270–5286. doi: 10.1128/JVI.03022-12
159
SleijferS.BanninkM.van GoolA. R.KruitW. H. J.StoterG. (2005). Side effects of interferon-alpha therapy. Pharm. World Sci.27, 423–431. doi: 10.1007/s11096-005-1319-7
160
SoboK.ChevallierJ.PartonR. G.GruenbergJ.van der GootF. G. (2007). Diversity of raft-like domains in late endosomes. PLoS One2:e391. doi: 10.1371/journal.pone.0000391
161
Soto-AcostaR.MossoC.Cervantes-SalazarM.Puerta-GuardoH.MedinaF.FavariL.et al. (2013). The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity. Virology442, 132–147. doi: 10.1016/j.virol.2013.04.003
162
SousaI. P.CarvalhoC. A. M.GomesA. M. O. (2020). Current understanding of the role of cholesterol in the life cycle of alphaviruses. Viruses13:35. doi: 10.3390/v13010035
163
SpannN. J.GarmireL. X.McDonaldJ. G.MyersD. S.MilneS. B.ShibataN.et al. (2012). Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell151, 138–152. doi: 10.1016/j.cell.2012.06.054
164
StoeckI. K.LeeJ.-Y.TabataK.Romero-BreyI.PaulD.SchultP.et al. (2018). Hepatitis C virus replication depends on endosomal cholesterol homeostasis. J. Virol.92, e01196–e01117. doi: 10.1128/JVI.01196-17
165
StoorvogelW.StrousG. J.GeuzeH. J.OorschotV.SchwartztA. L. (1991). Late endosomes derive from early endosomes by maturation. Cell65, 417–427. doi: 10.1016/0092-8674(91)90459-C
166
StrattonB. S.WarnerJ. M.WuZ.NikolausJ.WeiG.WagnonE.et al. (2016). Cholesterol increases the openness of SNARE-mediated flickering fusion pores. Biophys. J.110, 1538–1550. doi: 10.1016/j.bpj.2016.02.019
167
SunL.-P.SeemannJ.GoldsteinJ. L.BrownM. S. (2007). Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: Insig renders sorting signal in Scap inaccessible to COPII proteins. Proc. Natl. Acad. Sci. U. S. A.104, 6519–6526. doi: 10.1073/pnas.0700907104
168
SundquistW. I.KräusslichH.-G. (2012). HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med.2:a006924. doi: 10.1101/cshperspect.a006924
169
SzantoA.BenkoS.SzatmariI.BalintB. L.FurtosI.RühlR.et al. (2004). Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages. Mol. Cell. Biol.24, 8154–8166. doi: 10.1128/MCB.24.18.8154-8166.2004
170
TangY.LeaoI. C.ColemanE. M.BroughtonR. S.HildrethJ. E. K. (2009). Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in gag accumulation in late endosomal/lysosomal compartments. J. Virol.83, 7982–7995. doi: 10.1128/JVI.00259-09
171
ThakurS.RelichP. K.SorokinaE. M.GyparakiM. T.LakadamyaliM. (2020). ORP1L regulates dynein clustering on endolysosmal membranes in response to cholesterol levels. bioRxiv [Preprint]. doi: 10.1101/2020.08.28.273037
172
UHLERM.GARDS. (1954). Lipid content of standard and incomplete influenza A virus. Nature173, 1041–1042. doi: 10.1038/1731041a0
173
VenardosN.DengX.-S.YaoQ.WeyantM. J.ReeceT. B.MengX.et al. (2018). Simvastatin reduces the TLR4-induced inflammatory response in human aortic valve interstitial cells. J. Surg. Res.230, 101–109. doi: 10.1016/j.jss.2018.04.054
174
WangY.HaoJ.LiuX.WangH.ZengX.YangJ.et al. (2016). The mechanism of apoliprotein A1 down-regulated by hepatitis B virus. Lipids Health Dis.15:64. doi: 10.1186/s12944-016-0232-5
175
WangS.LiW.HuiH.TiwariS. K.ZhangQ.CrokerB. A.et al. (2020). Cholesterol 25-hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J.39:e106057. doi: 10.15252/embj.2020106057
176
WangQ.MaX.ChenY.ZhangL.JiangM.LiX.et al. (2014). Identification of interferon-γ as a new molecular target of liver X receptor. Biochem. J.459, 345–354. doi: 10.1042/BJ20131442
177
WangH.PerryJ.LauringA.NeddermannP.de FrancescoR.TaiA. (2014). Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology146, 1373.e1-11–1385.e1-11. doi: 10.1053/j.gastro.2014.02.002
178
WangX.SatoR.BrownM. S.HuaX.GoldsteinJ. L. (1994). SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell77, 53–62. doi: 10.1016/0092-8674(94)90234-8
179
WangY.ThieleC.HuttnerW. B. (2000). Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-Golgi network. Traffic1, 952–962. doi: 10.1034/j.1600-0854.2000.011205.x
180
WangF.XiaW.LiuF.LiJ.WangG.GuJ. (2012). Interferon regulator factor 1/retinoic inducible gene I (IRF1/RIG-I) axis mediates 25-hydroxycholesterol-induced interleukin-8 production in atherosclerosis. Cardiovasc. Res.93, 190–199. doi: 10.1093/cvr/cvr260
181
WangL.XieW.ZhangL.LiD.YuH.XiongJ.et al. (2018). CVB3 nonstructural 2A protein modulates SREBP1a signaling via the MEK/ERK pathway. J. Virol.92, e01060–e01018. doi: 10.1128/JVI.01060-18
182
WarisG.FelmleeD. J.NegroF.SiddiquiA. (2007). Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J. Virol.81, 8122–8130. doi: 10.1128/JVI.00125-07
183
WatariH.Blanchette-MackieE. J.DwyerN. K.GlickJ. M.PatelS.NeufeldE. B.et al. (1999). Niemann-pick C1 protein: obligatory roles for N-terminal domains and lysosomal targeting in cholesterol mobilization. Proc. Natl. Acad. Sci. U. S. A.96, 805–810. doi: 10.1073/pnas.96.3.805
184
WesterterpM.FotakisP.OuimetM.BochemA. E.ZhangH.MoluskyM. M.et al. (2018). Cholesterol efflux pathways suppress Inflammasome activation, NETosis, and Atherogenesis. Circulation138, 898–912. doi: 10.1161/CIRCULATIONAHA.117.032636
185
WilhelmL. P.WendlingC.VédieB.KobayashiT.ChenardM.-P.TomasettoC.et al. (2017). STARD3 mediates endoplasmic reticulum-to-endosome cholesterol transport at membrane contact sites. EMBO J.36, 1412–1433. doi: 10.15252/embj.201695917
186
WillardK. A.EllingC. L.SticeS. L.BrindleyM. A. (2018). The oxysterol 7-Ketocholesterol reduces Zika virus titers in Vero cells and human neurons. Viruses11:20. doi: 10.3390/v11010020
187
WillingerT. (2019). Oxysterols in intestinal immunity and inflammation. J. Intern. Med.285, 367–380. doi: 10.1111/joim.12855
188
XieS.BahlK.ReineckeJ. B.HammondG. R. V.NaslavskyN.CaplanS. (2016). The endocytic recycling compartment maintains cargo segregation acquired upon exit from the sorting endosome. Mol. Biol. Cell27, 108–126. doi: 10.1091/mbc.E15-07-0514
189
YandrapalliN.LubartQ.TanwarH. S.PicartC.MakJ.MuriauxD.et al. (2016). Self assembly of HIV-1 gag protein on lipid membranes generates PI(4,5)P2/cholesterol nanoclusters. Sci. Rep.6:39332. doi: 10.1038/srep39332
190
YangT.EspenshadeP. J.WrightM. E.YabeD.GongY.AebersoldR.et al. (2002). Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER. Cell110, 489–500. doi: 10.1016/S0092-8674(02)00872-3
191
YangY.ZhuZ.FanL.YeS.LouK.HuaX.et al. (2020). Low serum level of apolipoprotein A1 is an indicator of severity in patients with coronavirus disease 2019 [Preprint].
192
YokoyamaC.WangX.BriggsM. R.AdmonA.WuJ.HuaX.et al. (1993). SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell75, 187–197. doi: 10.1016/S0092-8674(05)80095-9
193
YuC.-Y.LiangJ.-J.LiJ.-K.LeeY.-L.ChangB.-L.SuC.-I.et al. (2015). Dengue virus impairs mitochondrial fusion by cleaving Mitofusins. PLoS Pathog.11:e1005350. doi: 10.1371/journal.ppat.1005350
194
YuY.MaguireT. G.AlwineJ. C. (2012). Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J. Virol.86, 2942–2949. doi: 10.1128/JVI.06467-11
195
YuanS.ChuH.ChanJ. F.-W.YeZ.-W.WenL.YanB.et al. (2019). SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat. Commun.10:120. doi: 10.1038/s41467-018-08015-x
196
Zamorano CuervoN.OssemanQ.GrandvauxN. (2018). Virus infection triggers MAVS polymers of distinct molecular weight. Viruses10:56. doi: 10.3390/v10020056
197
ZhangL.JuY.ChenS.RenL. (2021). Recent Progress on exosomes in RNA virus infection. Viruses13:256. doi: 10.3390/v13020256
198
ZhaoJ.ChenJ.LiM.ChenM.SunC. (2020). Multifaceted functions of CH25H and 25HC to modulate the lipid metabolism, immune responses, and broadly antiviral activities. Viruses12:727. doi: 10.3390/v12070727
199
ZhaoG.-J.YinK.FuY.-C.TangC.-K. (2012). The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids. Mol. Med.18, 149–158. doi: 10.2119/molmed.2011.00183
200
ZhengD.LiwinskiT.ElinavE. (2020). Inflammasome activation and regulation: toward a better understanding of complex mechanisms. Cell Discov.6:36. doi: 10.1038/s41421-020-0167-x
201
ZhuX.LeeJ.-Y.TimminsJ. M.BrownJ. M.BoudyguinaE.MulyaA.et al. (2008). Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem.283, 22930–22941. doi: 10.1074/jbc.M801408200
202
ZhuX.OwenJ. S.WilsonM. D.LiH.GriffithsG. L.ThomasM. J.et al. (2010). Macrophage ABCA1 reduces MyD88-dependent toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J. Lipid Res.51, 3196–3206. doi: 10.1194/jlr.M006486
203
ZuS.DengY.-Q.ZhouC.LiJ.LiL.ChenQ.et al. (2020). 25-hydroxycholesterol is a potent SARS-CoV-2 inhibitor. Cell Res.30, 1043–1045. doi: 10.1038/s41422-020-00398-1
Summary
Keywords
cholesterol, trafficking, viruses, endosomes, antivirals, host-factors
Citation
Glitscher M and Hildt E (2021) Endosomal Cholesterol in Viral Infections – A Common Denominator?. Front. Physiol. 12:750544. doi: 10.3389/fphys.2021.750544
Received
30 July 2021
Accepted
22 October 2021
Published
11 November 2021
Volume
12 - 2021
Edited by
Hester Gertruida O’Neill, University of the Free State, South Africa
Reviewed by
Cathleen Carlin, Case Western Reserve University, United States; Covadonga Alonso, Instituto Nacional de Investigación y Tecnología Agroalimentaria (INIA), Spain
Updates
Copyright
© 2021 Glitscher and Hildt.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Eberhard Hildt, eberhard.hildt@pei.de
This article was submitted to Lipid and Fatty Acid Research, a section of the journal Frontiers in Physiology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.